BRIEF-Ipsen Biopharmaceuticals Canada Reports Commercial Availability Of Increlex

Reuters · 03/16/2021 13:03
BRIEF-Ipsen Biopharmaceuticals Canada Reports Commercial Availability Of Increlex

- Ipsen SA IPN.PA:

  • IPSEN BIOPHARMACEUTICALS CANADA - ANNOUNCED COMMERCIAL AVAILABILITY OF INCRELEX FOR TREATMENT OF GROWTH FAILURE IN CHILDREN & ADOLESCENTS

Source text for Eikon: ID:nCNWjHYpCa

Further company coverage: IPN.PA


((Reuters.Briefs@thomsonreuters.com;))